Crinetics Pharmaceuticals Inc (CRNX)
44.41
-0.96
(-2.12%)
USD |
NASDAQ |
May 31, 16:00
44.45
+0.04
(+0.09%)
After-Hours: 20:00
Crinetics Pharmaceuticals 1 Year Total Returns (Daily): 103.4% for May 31, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 31, 2024 | 103.4% |
May 30, 2024 | 105.8% |
May 29, 2024 | 107.3% |
May 28, 2024 | 112.0% |
May 24, 2024 | 113.7% |
May 23, 2024 | 115.7% |
May 22, 2024 | 123.2% |
May 21, 2024 | 122.0% |
May 20, 2024 | 127.0% |
May 17, 2024 | 129.5% |
May 16, 2024 | 134.8% |
May 15, 2024 | 126.1% |
May 14, 2024 | 122.5% |
May 13, 2024 | 116.0% |
May 10, 2024 | 105.7% |
May 09, 2024 | 109.4% |
May 08, 2024 | 131.0% |
May 07, 2024 | 113.2% |
May 06, 2024 | 108.1% |
May 03, 2024 | 118.8% |
May 02, 2024 | 124.3% |
May 01, 2024 | 119.8% |
April 30, 2024 | 124.3% |
April 29, 2024 | 125.2% |
April 26, 2024 | 125.7% |
Date | Value |
---|---|
April 25, 2024 | 127.7% |
April 24, 2024 | 127.9% |
April 23, 2024 | 147.7% |
April 22, 2024 | 143.4% |
April 19, 2024 | 154.0% |
April 18, 2024 | 155.1% |
April 17, 2024 | 158.7% |
April 16, 2024 | 173.0% |
April 15, 2024 | 174.2% |
April 12, 2024 | 183.5% |
April 11, 2024 | 203.6% |
April 10, 2024 | 186.5% |
April 09, 2024 | 195.2% |
April 08, 2024 | 192.3% |
April 05, 2024 | 198.0% |
April 04, 2024 | 187.1% |
April 03, 2024 | 184.5% |
April 02, 2024 | 186.4% |
April 01, 2024 | 189.7% |
March 28, 2024 | 205.7% |
March 27, 2024 | 178.9% |
March 26, 2024 | 180.0% |
March 25, 2024 | 178.4% |
March 22, 2024 | 185.2% |
March 21, 2024 | 178.1% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-54.47%
Minimum
Mar 18 2020
205.7%
Maximum
Mar 28 2024
12.60%
Average
-1.88%
Median
Oct 12 2020
1 Year Total Returns (Daily) Benchmarks
Catalyst Pharmaceuticals Inc | 40.04% |
Geron Corp | 8.56% |
Madrigal Pharmaceuticals Inc | -15.13% |
PTC Therapeutics Inc | -13.32% |
Syndax Pharmaceuticals Inc | -3.51% |